HHealthcare Read More 2 Top AI Healthcare Stocks to Buy and HoldMarch 10, 2026 Many of the top companies successfully cashing in on artificial intelligence (AI) are in the technology sector. However,…
MMedication Read More List of medications seeing major price changes in 2026March 6, 2026 A number of major drugmakers have reportedly raised the prices of hundreds of brand-name drugs, including some of…
HHealthcare Read More This Dividend Giant Pfizer Could Turn a Boring Healthcare Allocation Into Serious IncomeFebruary 25, 2026 Pfizer (NYSE: PFE) is one of the world’s largest and most respected pharmaceutical companies. That is an important…
HHealthcare Read More Is Pfizer Stock an Underrated Healthcare Investment Play?February 21, 2026 Pharmaceutical giant Pfizer (NYSE: PFE) recently had to drop its internally developed GLP-1 weight loss drug candidate. The…
HHealthcare Read More Eli Lilly Soared by 39% in 2025, but Here’s Another Healthcare Stock to Buy in 2026February 4, 2026 Eli Lilly’s (NYSE: LLY) share price jumped 39% in 2025, driven by investors eager to benefit from the…
HHealthcare Read More Where Will Pfizer Be in 5 Years?January 2, 2026 Pfizer’s stock soared during the coronavirus pandemic because of its COVID-19 vaccine. The world has learned to live…
MMedication Read More Should You Buy Pfizer While It’s Under $30?January 1, 2026 Pfizer has been struggling for several years. The company’s pipeline could help it turn things around. It also…
HHealthcare Read More Better Buy in 2026: Pfizer or Eli Lilly?December 18, 2025 Eli Lilly has been a dominant force in the GLP-1 market, and that looks set to continue. Pfizer’s…
HHealthcare Read More Which Healthcare Giant Is the Better Bet?November 30, 2025 Novo Nordisk NVO and Pfizer PFE are pharmaceutical giants based in Denmark and the United States, respectively, with strong…
HHealthcare Read More How Recent Moves Are Rewriting the Story for PfizerNovember 15, 2025 Pfizer’s fair value estimate has inched upward recently, rising from $28.86 to $29.08 per share. The discount rate…
HHealthcare Read More Who’s Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market?November 13, 2025 Eli Lilly’s GLP-1 drug is now the world’s best-selling drug. Novo Nordisk is struggling with declining market share.…
MMedication Read More Why Weight-Loss Drug Prices Are Falling| Business NewsNovember 11, 2025 President Trump claimed credit Thursday for cutting prices on popular weight-loss drugs by Eli Lilly and Novo Nordisk.…